Plasmapheresis in the treatment of systemic lupus erythematosus. 1981

M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner

Plasmapheresis has been used as a supplementary method for the treatment of 11 cases of SLE (7 with lupus nephritis and 4 without renal changes). In 7 cases there was a marked improvement during the plasma exchanges which lasted from 2 months to 3 years of follow up. In one case the direct result was satisfactory but after 3 months there was a severe relapse and the patient died. In 3 cases (two without lupus nephritis) plasmapheresis was without any effect. We believe that plasmapheresis is chiefly indicated in severe cases with high levels of ds-DNA antibody titers.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear

Related Publications

M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
June 1977, British medical journal,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
February 1991, The Journal of rheumatology,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
March 1990, Harefuah,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
July 1990, Zhonghua nei ke za zhi,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
October 1982, Southern medical journal,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
January 1982, Progress in clinical and biological research,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
April 1979, Dermatologische Monatschrift,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
August 1985, Casopis lekaru ceskych,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
March 1997, Transfusion science,
M Błaszczyk, and T Chorzelski, and J Daszyński, and A Gaczkowski, and S Jabłońska, and E H Beutner
March 1983, Journal of the American Veterinary Medical Association,
Copied contents to your clipboard!